Emanuela Lapice

872 total citations
15 papers, 634 citations indexed

About

Emanuela Lapice is a scholar working on Physiology, Molecular Biology and Surgery. According to data from OpenAlex, Emanuela Lapice has authored 15 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 5 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Emanuela Lapice's work include Adipose Tissue and Metabolism (5 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Lipoproteins and Cardiovascular Health (3 papers). Emanuela Lapice is often cited by papers focused on Adipose Tissue and Metabolism (5 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Lipoproteins and Cardiovascular Health (3 papers). Emanuela Lapice collaborates with scholars based in Italy, Australia and United States. Emanuela Lapice's co-authors include Giuseppe Lucisano, Monica Franciosi, Giovanni FM Strippoli, Fabio Pellegrini, Antonio Nicolucci, Olga Vaccaro, Maria Masulli, Gabriele Riccardi, Angela A. Rivellese and Paola Cipriano and has published in prestigious journals such as PLoS ONE, Diabetes Care and International Journal of Obesity.

In The Last Decade

Emanuela Lapice

15 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emanuela Lapice Italy 10 367 196 139 121 105 15 634
Agnieszka Januś Poland 14 217 0.6× 125 0.6× 108 0.8× 72 0.6× 83 0.8× 31 739
Junna Yamaguchi Japan 11 213 0.6× 57 0.3× 136 1.0× 102 0.8× 85 0.8× 16 620
Stefania Iiritano Italy 9 445 1.2× 170 0.9× 111 0.8× 106 0.9× 107 1.0× 11 783
Eddy S. Konaniah United States 13 273 0.7× 59 0.3× 115 0.8× 111 0.9× 101 1.0× 17 752
Jamie L. Resnik United States 10 358 1.0× 134 0.7× 153 1.1× 93 0.8× 74 0.7× 13 688
Qian Yu China 13 269 0.7× 73 0.4× 105 0.8× 51 0.4× 71 0.7× 45 557
Rihong Cong China 13 177 0.5× 127 0.6× 79 0.6× 49 0.4× 94 0.9× 14 599
Hermann Joseph Gröne Germany 8 323 0.9× 45 0.2× 100 0.7× 88 0.7× 78 0.7× 8 863
Tomoe Kinoshita Japan 12 223 0.6× 87 0.4× 301 2.2× 58 0.5× 102 1.0× 34 592
Ning‐hua Cui China 13 209 0.6× 56 0.3× 78 0.6× 87 0.7× 95 0.9× 29 502

Countries citing papers authored by Emanuela Lapice

Since Specialization
Citations

This map shows the geographic impact of Emanuela Lapice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuela Lapice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuela Lapice more than expected).

Fields of papers citing papers by Emanuela Lapice

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emanuela Lapice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuela Lapice. The network helps show where Emanuela Lapice may publish in the future.

Co-authorship network of co-authors of Emanuela Lapice

This figure shows the co-authorship network connecting the top 25 collaborators of Emanuela Lapice. A scholar is included among the top collaborators of Emanuela Lapice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emanuela Lapice. Emanuela Lapice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Russo, Giuseppina, Francesco Andreozzi, Paolo Di Bartolo, et al.. (2022). Role of telemedicine during COVID-19 pandemic in type 2 diabetes outpatients: The AMD annals initiative. Diabetes Research and Clinical Practice. 194. 110158–110158. 14 indexed citations
2.
Luca, Mariarosaria De, Giorgio Bosso, Vincenzo Guardasole, et al.. (2020). Management of patients with chronic heart failure and type 2 diabetes mellitus: the SCODIAC-II study. Internal and Emergency Medicine. 16(4). 895–903. 7 indexed citations
3.
Lapice, Emanuela, Antonella Monticelli, Sergio Cocozza, et al.. (2016). The combination of UCP3–55CT and PPARγ2Pro12Ala polymorphisms affects BMI and substrate oxidation in two diabetic populations. Nutrition Metabolism and Cardiovascular Diseases. 26(5). 400–406. 1 indexed citations
4.
Lapice, Emanuela, Antonella Monticelli, Sergio Cocozza, et al.. (2015). The PPARγ2 Pro12Ala variant is protective against progression of nephropathy in people with type 2 diabetes. Journal of Translational Medicine. 13(1). 85–85. 10 indexed citations
5.
Lapice, Emanuela & Olga Vaccaro. (2014). Interaction Between Pro12Ala Polymorphism of PPARγ2 and Diet on Adiposity Phenotypes. Current Atherosclerosis Reports. 16(12). 462–462. 10 indexed citations
6.
Lapice, Emanuela, Maria Masulli, & Olga Vaccaro. (2013). Iron Deficiency and Cardiovascular Disease: An Updated Review of the Evidence. Current Atherosclerosis Reports. 15(10). 358–358. 58 indexed citations
7.
Franciosi, Monica, Giuseppe Lucisano, Emanuela Lapice, et al.. (2013). Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review. PLoS ONE. 8(8). e71583–e71583. 347 indexed citations
8.
Lapice, Emanuela, Antonella Monticelli, Sergio Cocozza, et al.. (2013). The energy intake modulates the association of the –55CT polymorphism of UCP3 with body weight in type 2 diabetic patients. International Journal of Obesity. 38(6). 873–877. 6 indexed citations
9.
Lapice, Emanuela, Paola Cipriano, L. Patti, et al.. (2012). Fasting APO B48 levels are associated with microalbuminuria in patients with type 2 diabetes. Acta Diabetologica. 49(5). 409–412. 1 indexed citations
10.
Lapice, Emanuela, Paola Cipriano, L. Patti, et al.. (2012). Fasting apolipoprotein B48 is associated with asymptomatic peripheral arterial disease in type 2 diabetic subjects: A case–control study. Atherosclerosis. 223(2). 504–506. 9 indexed citations
11.
Cosmo, Salvatore De, Sabrina Prudente, Olga Lamacchia, et al.. (2011). PPAR 2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case-control studies. Nephrology Dialysis Transplantation. 26(12). 4011–4016. 24 indexed citations
12.
Lapice, Emanuela, Michele Pinelli, Elisabetta Pisu, et al.. (2010). Uncoupling protein 2 G(-866)A polymorphism: a new gene polymorphism associated with C-reactive protein in type 2 diabetic patients C-reactive protein in type 2 diabetic patients. Cardiovascular Diabetology. 9(1). 68–68. 11 indexed citations
13.
Lapice, Emanuela, L. Patti, Paola Cipriano, et al.. (2009). Abdominal Adiposity Is Associated With Elevated C-Reactive Protein Independent of BMI in Healthy Nonobese People. Diabetes Care. 32(9). 1734–1736. 83 indexed citations
14.
Vaccaro, Olga, Emanuela Lapice, Antonella Monticelli, et al.. (2007). Pro12Ala Polymorphism of the PPARγ2 Locus Modulates the Relationship Between Energy Intake and Body Weight in Type 2 Diabetic Patients. Diabetes Care. 30(5). 1156–1161. 28 indexed citations
15.
Pinelli, Michele, Fabio Acquaviva, Sergio Cocozza, et al.. (2006). β2-adrenergic receptor and UCP3 variants modulate the relationship between age and type 2 diabetes mellitus. BMC Medical Genetics. 7(1). 85–85. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026